Scoring systems in the prediction of atrial fibrillation recurrence after surgical ablation

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Scoring systems in the prediction of atrial fibrillation recurrence after surgical ablation. / Lauritzen, Daniel J; Andersen, Frederik T; Modrau, Ivy S et al.

In: Journal of Cardiac Surgery, Vol. 37, No. 10, 10.2022, p. 3044-3049.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Lauritzen, Daniel J ; Andersen, Frederik T ; Modrau, Ivy S et al. / Scoring systems in the prediction of atrial fibrillation recurrence after surgical ablation. In: Journal of Cardiac Surgery. 2022 ; Vol. 37, No. 10. pp. 3044-3049.

Bibtex

@article{a64b1d279848400b977869860b825bbf,
title = "Scoring systems in the prediction of atrial fibrillation recurrence after surgical ablation",
abstract = "INTRODUCTION: More than every third patient experiences recurrent atrial fibrillation after surgical pulmonary vein ablation. However, it remains challenging to predict who will and who will not experience this event. Scoring systems containing baseline risk factors have been proposed as a complementary tool to identify patients at higher risk of experiencing atrial fibrillation recurrence. Therefore, the aim of this study was to assess the value of the scoring systems APPLE, CHA2 DS2 -VASc, and CHADS2 in predicting atrial fibrillation recurrence following surgical ablation.METHODS: In a retrospective study, we identified all patients undergoing concomitant pulmonary vein ablation during cardiac surgery. APPLE-, CHA2 DS2 -VASc-, and CHADS2 scores were calculated for each patient. Subsequently, the predictive value of the scoring systems on atrial fibrillation recurrence 3-12 months postablation was assessed using receiver operating characteristic curves and logistic regression analyses.RESULTS: Receiver operating characteristic curves showed the superiority of the APPLE scoring system with an area under the curve of 0.690 compared to 0.571 for CHA2 DS2 -VASc and 0.569 for CHADS2 , p = .01. Using logistic regression analyses, APPLE and CHA2 DS2 -VASc were predictors of atrial fibrillation recurrence between 3- and 12 months after surgical ablation (odds ratio [OR] 1.93, 95% confidence interval [CI] 1.39-2.67, p < .01 and OR 1.17, 95% CI 1.01-1.36, p = .04, respectively).CONCLUSIONS: The APPLE scoring system is superior to CHA2 DS2 -VASc and CHADS2 in predicting atrial fibrillation recurrence after surgical ablation. It can be used as a complementary tool to select the right candidates for surgical ablation and identify patients who need more frequent clinical and electrocardiogram controls.",
keywords = "cardiovascular research, coronary artery disease, CATHETER ABLATION, RHYTHM OUTCOMES, CHADS(2), CHA(2)DS(2)-VASC SCORES, Predictive Value of Tests, Recurrence, Stroke, Risk Assessment, Humans, Risk Factors, Retrospective Studies, Atrial Fibrillation/complications",
author = "Lauritzen, {Daniel J} and Andersen, {Frederik T} and Modrau, {Ivy S} and Christensen, {Thomas D} and Johan Heiberg",
note = "{\textcopyright} 2022 Wiley Periodicals LLC.",
year = "2022",
month = oct,
doi = "10.1111/jocs.16799",
language = "English",
volume = "37",
pages = "3044--3049",
journal = "Journal of Cardiac Surgery",
issn = "0886-0440",
publisher = "Wiley-Blackwell Publishing, Inc.",
number = "10",

}

RIS

TY - JOUR

T1 - Scoring systems in the prediction of atrial fibrillation recurrence after surgical ablation

AU - Lauritzen, Daniel J

AU - Andersen, Frederik T

AU - Modrau, Ivy S

AU - Christensen, Thomas D

AU - Heiberg, Johan

N1 - © 2022 Wiley Periodicals LLC.

PY - 2022/10

Y1 - 2022/10

N2 - INTRODUCTION: More than every third patient experiences recurrent atrial fibrillation after surgical pulmonary vein ablation. However, it remains challenging to predict who will and who will not experience this event. Scoring systems containing baseline risk factors have been proposed as a complementary tool to identify patients at higher risk of experiencing atrial fibrillation recurrence. Therefore, the aim of this study was to assess the value of the scoring systems APPLE, CHA2 DS2 -VASc, and CHADS2 in predicting atrial fibrillation recurrence following surgical ablation.METHODS: In a retrospective study, we identified all patients undergoing concomitant pulmonary vein ablation during cardiac surgery. APPLE-, CHA2 DS2 -VASc-, and CHADS2 scores were calculated for each patient. Subsequently, the predictive value of the scoring systems on atrial fibrillation recurrence 3-12 months postablation was assessed using receiver operating characteristic curves and logistic regression analyses.RESULTS: Receiver operating characteristic curves showed the superiority of the APPLE scoring system with an area under the curve of 0.690 compared to 0.571 for CHA2 DS2 -VASc and 0.569 for CHADS2 , p = .01. Using logistic regression analyses, APPLE and CHA2 DS2 -VASc were predictors of atrial fibrillation recurrence between 3- and 12 months after surgical ablation (odds ratio [OR] 1.93, 95% confidence interval [CI] 1.39-2.67, p < .01 and OR 1.17, 95% CI 1.01-1.36, p = .04, respectively).CONCLUSIONS: The APPLE scoring system is superior to CHA2 DS2 -VASc and CHADS2 in predicting atrial fibrillation recurrence after surgical ablation. It can be used as a complementary tool to select the right candidates for surgical ablation and identify patients who need more frequent clinical and electrocardiogram controls.

AB - INTRODUCTION: More than every third patient experiences recurrent atrial fibrillation after surgical pulmonary vein ablation. However, it remains challenging to predict who will and who will not experience this event. Scoring systems containing baseline risk factors have been proposed as a complementary tool to identify patients at higher risk of experiencing atrial fibrillation recurrence. Therefore, the aim of this study was to assess the value of the scoring systems APPLE, CHA2 DS2 -VASc, and CHADS2 in predicting atrial fibrillation recurrence following surgical ablation.METHODS: In a retrospective study, we identified all patients undergoing concomitant pulmonary vein ablation during cardiac surgery. APPLE-, CHA2 DS2 -VASc-, and CHADS2 scores were calculated for each patient. Subsequently, the predictive value of the scoring systems on atrial fibrillation recurrence 3-12 months postablation was assessed using receiver operating characteristic curves and logistic regression analyses.RESULTS: Receiver operating characteristic curves showed the superiority of the APPLE scoring system with an area under the curve of 0.690 compared to 0.571 for CHA2 DS2 -VASc and 0.569 for CHADS2 , p = .01. Using logistic regression analyses, APPLE and CHA2 DS2 -VASc were predictors of atrial fibrillation recurrence between 3- and 12 months after surgical ablation (odds ratio [OR] 1.93, 95% confidence interval [CI] 1.39-2.67, p < .01 and OR 1.17, 95% CI 1.01-1.36, p = .04, respectively).CONCLUSIONS: The APPLE scoring system is superior to CHA2 DS2 -VASc and CHADS2 in predicting atrial fibrillation recurrence after surgical ablation. It can be used as a complementary tool to select the right candidates for surgical ablation and identify patients who need more frequent clinical and electrocardiogram controls.

KW - cardiovascular research

KW - coronary artery disease

KW - CATHETER ABLATION

KW - RHYTHM OUTCOMES

KW - CHADS(2)

KW - CHA(2)DS(2)-VASC SCORES

KW - Predictive Value of Tests

KW - Recurrence

KW - Stroke

KW - Risk Assessment

KW - Humans

KW - Risk Factors

KW - Retrospective Studies

KW - Atrial Fibrillation/complications

U2 - 10.1111/jocs.16799

DO - 10.1111/jocs.16799

M3 - Journal article

C2 - 35870158

VL - 37

SP - 3044

EP - 3049

JO - Journal of Cardiac Surgery

JF - Journal of Cardiac Surgery

SN - 0886-0440

IS - 10

ER -